Maravai LifeSciences
Maravai LifeSciences, a leading provider in the life sciences sector, is headquartered in the United States and operates across key regions globally. Founded in 2016, the company has rapidly established itself as a pivotal player in the biotechnology industry, focusing on critical areas such as nucleic acid production, protein detection, and cell culture solutions. Maravai's core offerings include high-quality reagents and services that support the development of therapeutics and diagnostics. Their unique approach to custom synthesis and scalable production sets them apart in a competitive market. With a commitment to innovation, Maravai has achieved significant milestones, including strategic acquisitions that enhance their capabilities and market reach. Recognised for their excellence, Maravai LifeSciences continues to drive advancements in life sciences, contributing to the global health landscape.
DitchCarbon Score
How does Maravai LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Maravai LifeSciences's score of 38 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Maravai LifeSciences's reported carbon emissions
In 2024, Maravai LifeSciences reported total carbon emissions of approximately 19,000,000 kg CO2e. This includes Scope 1 emissions of about 862,580 kg CO2e, Scope 2 emissions of approximately 2,208,570 kg CO2e (market-based), and significant Scope 3 emissions totalling around 15,000,000 kg CO2e. The Scope 3 emissions are primarily driven by purchased goods and services (about 56,213,130 kg CO2e) and capital goods (approximately 10,027,390 kg CO2e). In 2023, the company recorded total emissions of about 14,000,000 kg CO2e, with Scope 1 emissions at approximately 736,590 kg CO2e and Scope 2 emissions of around 1,993,000 kg CO2e (market-based). The Scope 3 emissions for that year were significant, particularly from purchased goods and services (about 8,002,000 kg CO2e) and business travel (approximately 2,145,000 kg CO2e). Maravai LifeSciences has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. However, they have consistently reported emissions across all three scopes, indicating a commitment to transparency in their sustainability efforts. The company continues to monitor and report its carbon footprint, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 330,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,103,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Maravai LifeSciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
